Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: J Hypertens. 2013 Apr;31(4):820–829. doi: 10.1097/HJH.0b013e32835e8227

TABLE 1.

Volunteer characteristics in salt-resistant and salt-sensitive subjects at screening

Salt-resistant (N=17) Salt-sensitive (N=14)
Age (years) 45.7 ± 11.4 42.1 ± 11.8

Gender (male: female) 6 : 11 9 : 5

Race (white: black) 12 : 5 9 : 5

Body mass index (kg/m2) 29.3 ± 4.8 29.9 ± 6.6

Waist to hip ratio 0.90 ± 0.11 0.92 ± 0.15

Fasting glucose (mg/dl) 90.5 ± 10.6 88.2 ± 12.5

Triglycerides (mg/dl) 102.7 ± 73.4 103.3 ± 55.9

Cholesterol-HDL (mg/dl) 54.1 ± 20.0 52.1 ± 15.8

Mean arterial pressure (mmHg) 96.1 ± 8.6 95.9 ± 7.0

Systolic blood pressure (mmHg) 129.8 ± 14.4 129.9 ± 13.5

Diastolic blood pressure (mmHg) 79.2 ± 7.5 78.9 ± 5.5

Antihypertensive medications
 0 [N (%)] 3 (18%) 4 (29%)
 1 [N (%)] 8 (47%) 8 (57%)
 2 [N (%)] 6 (37%) 2 (14%)

Type of antihypertensive medication
 ACE inhibitor or ARB [N (%)] 12 (71%) 6 (43%)
 β-Blocker [N (%)] 2 (12%) 1 (7%)
 Thiazide diuretic [N (%)] 6 (35%) 5 (36%)

Screening measurements were made prior to the washout of antihypertensive medication. ACE, angiotensin-converting enzyme; HDL, high-density lipoprotein. Data presented as N, % or mean ± SD.